Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?
International Journal of Molecular Sciences · 05.04.2025 · 26 (7) · 3412
DOI: 10.3390/ijms26073412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.04.2025. Verfasst von Moritz Förster und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kliniken Maria Hilf GmbH, Academic Teaching Hospital of the RWTH Aachen University Hospital, 41063 Mönchengladbach, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, Biomarkers, Nitrosative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Multiple Sklerose Gesellschaft (DMSG) Ortsvereinigung (OV) Düsseldorf, Umgebung e.V..
Abstract (Originalsprache)
Multiple sclerosis (MS), an auto-immune disease of the central nervous system (CNS) with inflammatory and neurodegenerative properties, remains an insufficiently understood disease despite more than 150 years of research. In contrast to diseases from other medical fields such as, for instance, oncology, a description of its clinical and non-clinical features based on readouts such as biomarkers is still in its infancy. While, in this regard, neurofilament light chain (NfL) seems to be a promising new tool, the significant intra- and interindividual variation of this serological marker somewhat limits its widespread applicability in everyday clinical reality. This has sparked novel studies in which glial fibrillary acidic protein (GFAP) was proposed as an on-top marker serving to improve overall specificity. In this context, it was found that MS disease progression was significantly more often associated with increased levels of both NfL and GFAP compared to increased NfL levels alone. This highlights the complexity of the disease while also emphasizing the potential benefits of introducing additional markers to enhance current options. We propose that nitrosative stress markers, such as nitrate, nitrite, and nitrotyrosine (3NT), could serve this purpose effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Kliniken Maria Hilf GmbH, Academic Teaching Hospital of the RWTH Aachen University Hospital, 41063 Mönchengladbach, Germany.
- Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Neurology and Neurorehabilitation, Hospital Zum Heiligen Geist, Academic Teaching Hospital of the Heinrich Heine University Düsseldorf, 47906 Kempen, Germany.
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
ORCID-Profile: Moritz Förster, Saskia Räuber, Lars Wojtecki, Sven G Meuth
Förderung
- Deutsche Multiple Sklerose Gesellschaft (DMSG) Ortsvereinigung (OV) Düsseldorf
- Umgebung e.V.
Zitieren
APA
Förster, M., Räuber, S., Albrecht, P., Wojtecki, L., Meuth, S. G., & Kremer, D. (2025). Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?. International Journal of Molecular Sciences, 26(7), 3412. https://doi.org/10.3390/ijms26073412
Vancouver
Förster M, Räuber S, Albrecht P, Wojtecki L, Meuth SG, Kremer D. Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?. International Journal of Molecular Sciences. 2025;26(7):3412. doi:10.3390/ijms26073412
BibTeX
@article{Frster2025,
author = {Förster, Moritz and Räuber, Saskia and Albrecht, Philipp and Wojtecki, Lars and Meuth, Sven G and Kremer, David},
title = {Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {7},
pages = {3412},
doi = {10.3390/ijms26073412}
}
EUVIMED